Tuesday, November 24, 2009, 9:28pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

ARYx Therapeutics, Inc. (ARYX)

 At 16:00 EST: 2.50 USD  Up 0.03 (1.21%)  
MORE ON ARYX
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
ARYx Therapeutics, Inc. (NGM:ARYX) Delayed quote dataEdit
After Hours: 2.50 Down 0.00 (0.02%) as of 4:15pm EST on 11/24/09
Last Trade: 2.50 USD
Trade Time: 4:00PM EST
Change: Up 0.03 (1.21%)
Prev Close: 2.47
Open: 2.49
Bid: 1.60 x 100
Ask: 3.44 x 100
1y Target Est: 17.33
Day's Range: 2.48 - 2.54
52wk Range: 1.30 - 6.32
Volume: 33,224
Avg Vol (3m): 75,422.7
Market Cap: 68.97M
P/E (ttm): N/A
EPS (ttm): -1.94
Div & Yield: N/A (N/A%)
ARYx Therapeutics, Inc. (ARYX)
1d  5d  3m  6m  1y  2y  5y 
 Add ARYX to Portfolio   Download Data

HEADLINES
• ARYX THERAPEUTICS, INC. Financials
EDGAR Online Financials (Wed, Nov 18)
• Results From Phase 2b Study on Atrial Fibrillation Agent Reviewed at American Heart Association
Business Wire (Wed, Nov 18)
• New Star Analyst Rankings for ARYx Therapeutics, Inc.
StarMine (Sun, Nov 15)
• ARYX THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 13)
• Aryx Therapeutics reports $8.2M loss
at bizjournals.com (Thu, Nov 12)
• Third Quarter 2009 Results and Earnings Call scheduled for 11:00 am ET today
Shareholder.com (Thu, Nov 12)
• ARYx Therapeutics Reports Third Quarter 2009 Results
Business Wire (Thu, Nov 12)
• Q3 2009 ARYx Therapeutics Earnings Release - Time Not Supplied
CCBN (Thu, Nov 12)
• ARYX THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
EDGAR Online (Thu, Nov 12)
• ARYx Therapeutics Schedules Third Quarter 2009 Results Conference Call
Business Wire (Thu, Nov 5)
More Headlines for ARYX...
ANALYST
EPS Est (next year) (Dec-07) : N/A
EPS Est (in 2 years) (Dec-08) : N/A
Avg Rec (current)*: 1.6
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
ARYx Therapeutics, Inc., a biopharmaceutical company, focuses on developing a portfolio of product candidates to eliminate known safety issues associated with commercial drugs.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices